1. Home
  2. CAE vs ROIV Comparison

CAE vs ROIV Comparison

Compare CAE & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CAE
  • ROIV
  • Stock Information
  • Founded
  • CAE 1947
  • ROIV 2014
  • Country
  • CAE Canada
  • ROIV United Kingdom
  • Employees
  • CAE N/A
  • ROIV N/A
  • Industry
  • CAE
  • ROIV Biotechnology: Pharmaceutical Preparations
  • Sector
  • CAE
  • ROIV Health Care
  • Exchange
  • CAE Nasdaq
  • ROIV Nasdaq
  • Market Cap
  • CAE 8.1B
  • ROIV 8.4B
  • IPO Year
  • CAE N/A
  • ROIV N/A
  • Fundamental
  • Price
  • CAE $24.58
  • ROIV $10.67
  • Analyst Decision
  • CAE Buy
  • ROIV Buy
  • Analyst Count
  • CAE 3
  • ROIV 4
  • Target Price
  • CAE $32.00
  • ROIV $17.50
  • AVG Volume (30 Days)
  • CAE 442.1K
  • ROIV 5.9M
  • Earning Date
  • CAE 05-13-2025
  • ROIV 05-29-2025
  • Dividend Yield
  • CAE N/A
  • ROIV N/A
  • EPS Growth
  • CAE N/A
  • ROIV N/A
  • EPS
  • CAE 0.88
  • ROIV N/A
  • Revenue
  • CAE $3,275,402,649.00
  • ROIV $122,585,000.00
  • Revenue This Year
  • CAE $11.49
  • ROIV N/A
  • Revenue Next Year
  • CAE $6.91
  • ROIV N/A
  • P/E Ratio
  • CAE $27.81
  • ROIV N/A
  • Revenue Growth
  • CAE 9.93
  • ROIV 140.04
  • 52 Week Low
  • CAE $15.95
  • ROIV $8.73
  • 52 Week High
  • CAE $27.62
  • ROIV $13.06
  • Technical
  • Relative Strength Index (RSI)
  • CAE 47.96
  • ROIV 47.82
  • Support Level
  • CAE $25.38
  • ROIV $10.58
  • Resistance Level
  • CAE $26.63
  • ROIV $11.77
  • Average True Range (ATR)
  • CAE 0.57
  • ROIV 0.34
  • MACD
  • CAE 0.04
  • ROIV -0.07
  • Stochastic Oscillator
  • CAE 22.05
  • ROIV 7.56

About CAE CAE Inc.

CAE Inc provides training and aviation services, integrated enterprise solutions, in-service support, and crew-sourcing services. The company operations are managed through two segments: Civil Aviation which offers comprehensive training solutions for flight, cabin, maintenance, and ground personnel in commercial, business, and helicopter aviation, a complete range of flight simulation training devices, ab initio pilot training, and crew sourcing services, as well as aircraft flight operations solutions; and Defense and Security which is a global training and simulation provider delivering scalable, platform-independent solutions that enable and enhance force readiness and security. It generates the majority of its revenue from the Civil Aviation segment.

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

Share on Social Networks: